Related Experiment Videos
[Amyloidosis-a dreaded complication of juvenile chronic arthritis (JCA). (author's transl)]
Insights
This study details juvenile chronic arthritis (JCA) complicated by amyloidosis in 60 children. Early diagnosis and treatment with cytostatic drugs like chlorambucil can improve outcomes for this severe JCA complication.
Area of Science:
- Rheumatology
- Nephrology
- Pediatrics
Context:
- Juvenile chronic arthritis (JCA) can lead to severe systemic complications.
- Amyloidosis is a significant, often fatal, sequela in children with JCA.
- High inflammatory activity in systemic JCA is a primary driver of amyloidosis.
Purpose:
- To describe the symptoms, clinical course, and prognosis of childhood amyloidosis secondary to JCA.
- To identify early diagnostic markers and effective treatment strategies for JCA-associated amyloidosis.
- To analyze survival outcomes and identify distinct subgroups within JCA-related amyloidosis.
Summary:
- The study analyzed 60 pediatric patients with JCA complicated by amyloidosis.
- Proteinuria was the most common early sign.
- Amyloidosis and its sequelae were a major cause of mortality, linked to 27 of 90 deaths in the JCA unit.
- Early diagnosis and treatment with cytostatic agents, such as chlorambucil, showed potential for improved prognosis.
- Survival analysis suggested the existence of two distinct subgroups of JCA-associated amyloidosis.
Impact:
- Highlights amyloidosis as a critical cause of mortality in JCA patients.
- Emphasizes the importance of early detection through markers like proteinuria.
- Suggests cytostatic therapy as a promising avenue for improving JCA-associated amyloidosis outcomes.
- Provides insights into prognostic factors and potential therapeutic targets for JCA-related systemic amyloidosis.
Abstract:
Our studies describe symptoms, clinical course and prognosis of 60 children (out of a total of 2063 patients) suffering from chronic arthritis complicated with amyloidosis. Amyloidosis is predominantly caused by the systemic subgroup of juvenile chronic arthritis, which is characterized by high inflammation activity. The amyloidosis and the sequelae are one of the main causes of death in JCA (27 of the 90 lethal cases in our juvenile chronic arthritis unit were connected with amyloidosis). Proteinuria is the most frequent sign in the early stage of the amyloidosis. Early diagnose and treatment by cytostatic drugs like chlorambucil seems to improve the prognosis. The cumulative survival results in the existence of two different subgroup of amyloidosis.